From: Interventional cardiovascular magnetic resonance: state-of-the-art
Author | Year | Number of patients | Field strength (T) | Patient population | Comments |
---|---|---|---|---|---|
Razavi et al. [3] | 2003 | 16 | 1.5 | Pediatric and adult congenital | Non-metallic guidewire |
Muthurangu et al. [19] | 2004 | 24 | 1.5 | Pediatric and adult congenital | Â |
Kuehne et al. [99] | 2005 | 15 | 1.5 | Pediatric and adult | Â |
Ratnayaka et al.[11] | 2013 | 16 | 1.5 | Adult | Â |
Rogers et al. [20] | 2017 | 102 | 1.5 | Adult | Â |
Ratnayaka et al. [8] | 2017 | 39 | 1.5 | Pediatric | Â |
Campbell-Washburn et al.[5] | 2018 | 7 | 1.5 | Adult | Low-SAR imaging with nitinol guidewire |
Knight et al.[12] | 2019 | 50 | 1.5 | Adult | Â |
Campbell-Washburn et al. [6] | 2019 | 7 | 0.55 | Adult | Low-field imaging with nitinol guidewire |
Veeram Reddy et al. [4] | 2020 | 34 | 1.5 | Pediatric and adult congenital | Non-metallic guidewire |
Velasco Forte et al. [100] | 2021 | 30 | 1.5 | Pediatric and adult congenital | Â |
Greer et al. [101] | 2022 | 60 | 1.5 | Pediatric and adult congenital | T1-overlay visualization technique |